: MALDI-TOF MS profiles of the permethylated O-linked glycans derived from SRECs. For complete annotation of the spectrum, see Table S2 . Data were obtained from the 35% acetonitrile fraction and all molecular ions are present in sodiated form ([M+Na]+).
Taken together, these data indicate that for non-sialylated glycans the +30 addition was associated with HexNAc residues and for sialylated glycans the +30 addition was associated with both a switch from NeuAc to NeuGc and modification of HexNAc residues.
Unexpectedly, in addition to modulating sialic acids, mannosamine precursors also altered GlcNAc and GalNAc moieties on SREC N-and O-glycans, respectively. Other studies have examined the effects of precursors (1) (2) (3) (4) (5) , but have analyzed only the effect on sialylated structures (not on the pool of N-and O-glycans), and as such have not observed the unique changes in GlcNAc and GalNAc (6). Luchansky et al. showed that expression of GlcNAc 2-epimerase in Jurkat cells suppresses sialic acid production in response to exogenous addition of ManNAc and analogs of ManNAc (7) . The interpretation of our results is that GlcNAc 2-epimerase converts ManNGc into GlcNGc, which is then incorporated into N-glycans. GlcNGc is also converted to UDP-GalNGc in several steps, which is incorporated into O-glycans. Another possible explanation for the observed difference between our results and those of others could be that GlcNAc 2-epimerase is permissive for ManNGc, but not for more distant structural analogs of ManNAc, such as N-levulinoylmannosamine or 3-azido-3-deoxymannosamine. The decrease in virus infectivity after ManNGc treatment of SRECs could be due to conversion of NeuAc to NeuGc, from GlcNAc/GalNAc to GlcNGc/GalNGc (for N-and O-linked glycans, respectively), or both. However, we believe the most likely explanation is a conversion from NeuAc to NeuGc. First, GlcNAc/GalNAc remained the majority species throughout our studies (Fig. S4) . Second, when SRECs are treated with both precursors simultaneously, the 30 Da increment satellite signals are present, indicating the presence of GlcNGc/GalNGc (Fig. S4) . However, in these cells the virus infectivity levels are similar to levels in untreated cells (Fig. 4) , demonstrating that the amount of GlcNGc/GalNGc in cells treated with both precursors does not affect infectivity. Third, structures of virus HA complexed with sialylated glycans indicate that the GlcNAc moiety either does not make substantial interactions with HA (8) (9) (10) (11) or the GlcNAc makes only one interaction, with HA residue 190 contacting the acetamido nitrogen of GlcNAc (12, 13) . This interaction is maintained in both GlcNAc/GalNAc and GlcNGc/GalNGc, so conversion to GlcNGc/GalNGc would not be expected to have a substantial impact. Thus, the N-acyl group of NeuAc appears to play a larger role in HA-Sia binding than the N-acyl group of GlcNAc/GlcNGc, indicating that the infectivity changes we observe are likely due to the conversion of NeuAc to NeuGc.
